SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-20-008239
Filing Date
2020-09-01
Accepted
2020-09-01 15:07:55
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27671
2 filename2.txt TEXT-EXTRACT 1508
  Complete submission text file 0000000000-20-008239.txt   40398
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filed for) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2835 In Vitro & In Vivo Diagnostic Substances